Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists

Samuel J. Galgano; Ajaykumar C. Morani; Dheeraj R. Gopireddy; Kedar Sharbidre; David D.B. Bates; Ajit H. Goenka; Hina Arif-Tiwari; Malak Itani; Amir Iravani; Sanaz Javadi; Silvana Faria; Chandana Lall; Emily Bergsland; Sadhna Verma; Isaac R. Francis; Daniel M. Halperin; Deyali Chatterjee; Priya Bhosale; Motoyo Yano

doi:10.1007/s00261-022-03466-9

Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists

Samuel J. Galgano, Ajaykumar C. Morani, Dheeraj R. Gopireddy, Kedar Sharbidre, David D.B. Bates, Ajit H. Goenka, Hina Arif-Tiwari, Malak Itani, Amir Iravani, Sanaz Javadi, Silvana Faria, Chandana Lall, Emily Bergsland, Sadhna Verma, Isaac R. Francis, Daniel M. Halperin, Deyali Chatterjee, Priya Bhosale, Motoyo Yano

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.

Original language	English (US)
Pages (from-to)	3962-3970
Number of pages	9
Journal	Abdominal Radiology
Volume	47
Issue number	12
DOIs	https://doi.org/10.1007/s00261-022-03466-9
State	Published - Dec 2022

Keywords

Neuroendocrine
PaNEN
Pancreas

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Gastroenterology
Urology

Access to Document

10.1007/s00261-022-03466-9

Cite this

Galgano, S. J., Morani, A. C., Gopireddy, D. R., Sharbidre, K., Bates, D. D. B., Goenka, A. H., Arif-Tiwari, H., Itani, M., Iravani, A., Javadi, S., Faria, S., Lall, C., Bergsland, E., Verma, S., Francis, I. R., Halperin, D. M., Chatterjee, D., Bhosale, P., & Yano, M. (2022). Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists. Abdominal Radiology, 47(12), 3962-3970. https://doi.org/10.1007/s00261-022-03466-9

Galgano, SJ, Morani, AC, Gopireddy, DR, Sharbidre, K, Bates, DDB, Goenka, AH, Arif-Tiwari, H, Itani, M, Iravani, A, Javadi, S , Faria, S, Lall, C, Bergsland, E, Verma, S, Francis, IR, Halperin, DM , Chatterjee, D , Bhosale, P & Yano, M 2022, 'Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists', Abdominal Radiology, vol. 47, no. 12, pp. 3962-3970. https://doi.org/10.1007/s00261-022-03466-9

@article{cc4efe3b85674aa2ba1f705f914e3844,

title = "Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists",

abstract = "Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.",

keywords = "Neuroendocrine, PaNEN, Pancreas",

author = "Galgano, {Samuel J.} and Morani, {Ajaykumar C.} and Gopireddy, {Dheeraj R.} and Kedar Sharbidre and Bates, {David D.B.} and Goenka, {Ajit H.} and Hina Arif-Tiwari and Malak Itani and Amir Iravani and Sanaz Javadi and Silvana Faria and Chandana Lall and Emily Bergsland and Sadhna Verma and Francis, {Isaac R.} and Halperin, {Daniel M.} and Deyali Chatterjee and Priya Bhosale and Motoyo Yano",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2022",

month = dec,

doi = "10.1007/s00261-022-03466-9",

language = "English (US)",

volume = "47",

pages = "3962--3970",

journal = "Abdominal Radiology",

issn = "2366-004X",

publisher = "Springer New York",

number = "12",

}

TY - JOUR

T1 - Pancreatic neuroendocrine neoplasms

T2 - a 2022 update for radiologists

AU - Galgano, Samuel J.

AU - Morani, Ajaykumar C.

AU - Gopireddy, Dheeraj R.

AU - Sharbidre, Kedar

AU - Bates, David D.B.

AU - Goenka, Ajit H.

AU - Arif-Tiwari, Hina

AU - Itani, Malak

AU - Iravani, Amir

AU - Javadi, Sanaz

AU - Faria, Silvana

AU - Lall, Chandana

AU - Bergsland, Emily

AU - Verma, Sadhna

AU - Francis, Isaac R.

AU - Halperin, Daniel M.

AU - Chatterjee, Deyali

AU - Bhosale, Priya

AU - Yano, Motoyo

PY - 2022/12

Y1 - 2022/12

N2 - Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.

AB - Pancreatic neuroendocrine neoplasms (PaNENs) are a unique group of pancreatic neoplasms with a wide range of clinical presentations and behaviors. Given their heterogeneous appearance and increasing detection on cross-sectional imaging, it is essential that radiologists understand the variable presentation and distinctions PaNENs display compared to other pancreatic neoplasms. Additionally, some of these neoplasms may be hormonally functional, and it is imperative that radiologists be aware of the common clinical presentations of hormonally active PaNENs. Knowledge of PaNEN pathology and treatments may influence which imaging modality is optimal for each patient. Each imaging modality used for PaNENs has distinct advantages and disadvantages, particularly in different treatment settings. Thus, the focus of this manuscript is to provide an update for the radiologist on PaNEN pathology, imaging, and treatments.

KW - Neuroendocrine

KW - PaNEN

KW - Pancreas

UR - http://www.scopus.com/inward/record.url?scp=85126031791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85126031791&partnerID=8YFLogxK

U2 - 10.1007/s00261-022-03466-9

DO - 10.1007/s00261-022-03466-9

M3 - Review article

C2 - 35244755

AN - SCOPUS:85126031791

SN - 2366-004X

VL - 47

SP - 3962

EP - 3970

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 12

ER -

Pancreatic neuroendocrine neoplasms: a 2022 update for radiologists

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this